Viewing Study NCT02784158


Ignite Creation Date: 2025-12-24 @ 11:58 PM
Ignite Modification Date: 2026-02-23 @ 3:02 PM
Study NCT ID: NCT02784158
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2018-02-06
First Post: 2016-05-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Expanded Access Study of Brigatinib for Patients With ALK-positive Advanced Non-Small Cell Lung Cancer
Sponsor: Ariad Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module